Newpath Partners Launches Fund II to Create Life Sciences Companies

/PRNewswire/ -- Newpath Partners, a venture firm dedicated to life science investments, today announced the launch of Fund II. With its second fund in three...

Related Keywords

Boston ,Massachusetts ,United States ,Whitehead Institute ,Massachusetts Institute Of Technology ,Harvard University ,Catherine Stehman Breen ,Thomasj Cahill ,Siddhartha Mukherjee ,Daniel Getts ,Jim Wells ,Michael Rosbash ,Keith Joung ,Matt Ottmer ,Ben Cravatt ,Stuart Schreiber ,Thomas Cahill ,Michael Bruce ,Luba Greenwood ,Stephen Pagliuca ,David Liu ,Vic Meyer ,Keith Gottesdiener ,Jonathan Weissman ,Ron Vale ,Scripps Research Institute ,Brandeis University ,Harvard Medical School ,Columbia University Medical Center ,Professor At Harvard University ,Janelia Research Campus ,Newpath Fund ,Broad Institute Of Harvard ,Founder Of The Broad Institute ,University Of California San Francisco ,Newpath Partners ,Stop Covid ,Massachusetts General Hospital ,Broad Institute ,Executive Director ,Massachusetts Institute ,California San Francisco ,Chroma Medicine ,Nexo Therapeutics ,Kisbee Therapeutics ,Kojin Therapeutics ,Myeloid Therapeutics ,Prime Medicine ,Bain Capital ,Boston Celtics ,Chief Executive Officer ,P ,